Background: Uncontrolled blood pressure (BP), among patients diagnosed and treated for the condition, remains an important clinical challenge; aspects of clinical operations could potentially be adjusted if they were associated with better outcomes.
H ypertension (HTN) affects nearly 33% of American adults and is a major risk factor for cardiovascular, cerebrovascular, and renal disease. 1 Many diagnosed and treated patients have uncontrolled HTN. 1 Improving blood pressure (BP) control remains an important public health goal. 2 BP control is a widely used epidemiologic or quality metric. Normalization of uncontrolled BP after an episode of poor control may be a useful quality improvement outcome for health systems. 3 BP normalization is likely sensitive to aspects of clinical operations such as clinician staffing or appointment volume, which influence access to good primary care (eg, repeated BP measurements, prescribed medication, ongoing medication changes in response to poor control). 3 In economic productivity models, health care is produced when a series of "inputs" (finite resources, eg, clinician staffing) are deployed to produce "outputs" (better patient health, eg, controlled BP). When increased inputs lead to less than proportional increases in output, organizations experience "decreasing returns to scale" (eg, the number of patient appointments increases despite finite numbers of clinicians, limiting the pace at which patients can be seen). Thus, we posit that clinician staffing and appointment volume may affect BP care and outcomes.
Prior efforts to improve BP care through systematic programs and interventions (eg, clinical pharmacist monitoring, counseling, and medication titration) have had some success, [4] [5] [6] [7] but not all care systems can implement such programs. Nonetheless, if they led to better outcomes, some aspects of clinical operations could be adjusted. Thus, we examined, in a cohort of HTN patients, relationships between aspects of clinical operations and the probability of BP normalization (hereafter, "normalization") after an episode of elevated BP. 3, 8 
METHODS

Data Sources and Organization
We obtained deidentified data, organized by personmonth, from the clinical data system of the multiclinic General Internal Medicine practice of a single, urban, safetynet hospital, using i2b2 software. 9 BP data were from the electronic medical record, as entered and used by the clinical staff. Individual providers were linked to patients at the start of an episode of uncontrolled HTN (defined below). We obtained administrative data on Primary Care Provider (PCP) staffing-numbers of full-time equivalent (FTE) and unique PCPs, including both MDs and nurse practitioners; there were no physician's assistants.
Sample and Definitions
BP measurements were taken routinely in internal medicine (87% of visits). We selected all adults with a diagnosis of essential HTN (entered by clinicians on the problem list or as a billing code in the electronic medical record) between January 1, 2005 and December 31, 2009. We defined an episode of uncontrolled HTN as 2 consecutive primary care visits (for any reason; concurrent with or after a diagnosis of HTN) with uncontrolled BP (either systolic BPZ140 or diastolic BPZ90) within a 90-day period. The episode starts on the date of the second visit and we counted calendar months. If the patient normalized in the same month their episode began, that was considered "month 1."
We followed each patient for 12 months after episode start or until BP normalization, whichever came first. BP normalization occurs on the earliest date when the average of the 2 most recent systolic/diastolic BP measures (from 2 separate dates) fell below 140 (and 90).
We used 2 consecutive elevated BP measurements to start an episode and a moving average of 2 to end it because individual measures of BP are highly variable and averages more accurately reflect BP-related health status. 10 For patients with more than 1 eligible episode we selected 1 at random. Accrual of patients into the study cohort is depicted in Figure 1 .
Variables
Four independent variables captured aspects of clinical operations for each calendar month, categorized into quintiles for modeling: 
Covariates
We included sociodemographic indicators previously associated with BP outcomes (age, sex, race, language). We also included comorbid conditions that might affect BP management or make control more difficult, either because who has uncontrolled hypertension that does not normalize after a year but is censored at 12 months; Patient 2, a patient who has uncontrolled blood pressure that does normalize within a year; Patient 3, a patient with uncontrolled blood pressure who was enrolled late in the cohort accrual process, and followed into the period when no new patients were enrolled; Patient 4, a patient who was not eligible for enrollment into the cohort. The arrows refer to the point of 1) identification of the patient, 2) enrollment in the cohort (or determination of ineligibility for the cohort), and 3) the availability of information that showed the patient was not eligible. The dashed lines indicate the period over which the patient was followed or censored.
of direct effects of the conditions, associated risk factors, or medications used to treat them (benign prostatic hypertrophy, coronary artery disease, congestive heart failure, cerebrovascular disease, diabetes, hyperlipidemia, peripheral vascular disease, renal disease, tobacco use).
We included indicators for calendar month to recognize seasonal variations in BP, 11 calendar year to control for secular trends in BP management, 1 and a count of the number of months since episode start (reasoning that the more time elapsed without having previously achieved control, the lower the odds of achieving it later).
Analyses
We examined the probability of BP normalization in any given month, modeled as a function of the 4 clinical operations variables included simultaneously and adjusted for covariates; the dependent variable was an indicator set to 1 in the month when BP normalized and zero otherwise. We used discrete time duration analysis, a technique which creates separate observations for each person-month, facilitating inclusion of time-varying covariates like clinical operations variables, and allowing for estimation by probit regression. 12 Straightforward estimation of the above-described model would generate biased results due to BP data that is missing not at random with respect to the outcome. BP is only observed at clinic visits, and health status is likely to affect both the probability of having a clinic visit and normalization. To address these following accepted econometric techniques, 13 we use a 2-equation statistical model, one estimating the probability of BP normalization (BP normalization equation) and the second, simultaneously estimating by maximum likelihood the probability of observing BP (BP observation equation); disturbance terms were correlated across models.
Estimating both equations simultaneously requires that the predictor variables differ between the 2 equations, to "identify" the model. Thus, the BP observation equation included 2 additional variables: distance from patient residence to clinic, and number of days between the 2 primary care visits with elevated BP defining the episode start. We reasoned that (1) living farther away leads to fewer visits and less likelihood of being seen in any month, and (2) patients with longer intervals between their first 2 visits may also see their PCPs less often in the future. The model was estimated in STATA (version 10) using the "heckprob" command, clustering on individuals.
RESULTS
The sample of 50,403 person-months reflected experiences of 7409 distinct patients (Table 1) . They were 61% African American, 11% Hispanic, 15% white, and 13% other race; 8% spoke Spanish, and 14%, Haitian Creole. Common comorbidities included diabetes (28%), coronary artery disease (8%), renal disease (7%), and tobacco use (10%). Table 2 describes the person-months data. The mean clinician appointments per person-month were 115.8, the mean overall appointments were 6641.1, the mean staffing was 30.3, and the mean unique PCPs was 69.3. The mean time to normalization was 5 months (median, 4 mo), and 4% did not normalize within 12 months. The total number of individual clinician appointments was not strongly correlated with the clinic-level variables (maximum r = 0.09). Cliniclevel FTEs were only moderately correlated with clinic-level appointments and unique PCPs (maximum r = 0.47), ameliorating concerns about collinearity. *Analyses were not conducted at the individual patient level, but rather at the level of person-months. We provide descriptive information at the patient level here for reference only; see Table 2 for descriptive information about the person-month variables included in the analyses. BP normalization was less likely for episodes of uncontrolled BP starting in months when the number of unique PCPs was high ( Table 3 ). The marginal effect of the top quintile of the number of unique PCPs indicates that the probability of normalization was reduced by 9 percentage points (P < 0.01) from the lowest quintile.
Practice appointment volume also negatively affected the likelihood of normalization. The marginal effect for episodes of uncontrolled BP starting in months with the most appointments (top quintile) was a 6 percentage point decrease in the probability of normalization (P = 0.01). The marginal effects for the fourth, third, and second quintiles of this variable were also negative and declining in magnitude (4, 3, and 3 percentage points, respectively, all P'sr0.05).
Neither clinician volume nor practice staffing levels was significantly associated with the probability of normalization.
Several patient covariates affected the probability of normalization. Older patients-especially those over 65and those with renal dysfunction were less likely to normalize; however, patients with benign prostatic hypertrophy and tobacco use were more likely to normalize.
Results from the BP observation model (Table 4) show that the BP values were more likely to be observed in months in which the patient's clinician had high appointment volume, with high numbers of unique PCPs, and with high practice appointment volume. Older patients, females and patients with high cholesterol, peripheral vascular disease, or renal disease were more likely to have BP values observed.
Patients living farther from the clinic were less likely to have observed BP values (P < 0.01), as were those with more days between the first 2 primary care visits (P < 0.01). The estimated correlation between disturbance (error) terms in the 2 equations was [À 0.78 (P < 0.01)], indicating that unobservable factors making BP observation more likely tended to make BP normalization less likely. The magnitude and statistical significance of this correlation, and a sensitivity analysis in which a single equation that did not correct for observation bias found no significant effects of any clinical observation variables, both indicate the need to estimate the 2 equations simultaneously.
DISCUSSION
We examined the aspects of clinical operations and the probability of BP normalization following an episode of elevated BP among a cohort of HTN patients. Lower likelihood of BP normalization in months with higher numbers of unique PCPs suggests that increasing the absolute number of PCPs (holding FTEs constant) does not necessarily lead to better clinical outcomes. The association of higher practice appointment volume with lower likelihood of BP normalization, even after controlling for individual clinicians' appointment volume, suggests that when practices are busier, BP care may suffer. The greater likelihood of observing BP in months with higher clinician or practice appointment volume or with high numbers of unique PCPs, indirectly suggests better access to care, but the negative associations of the latter 2 with BP normalization suggests decrements in such care. The few prior studies on clinical operations factors' effects on BP outcomes found an association between more clinic visits/day per physician and higher systolic BPs 14 ; another study found no association between practice case load and BP control. 15 We know of no studies simultaneously examining the effects of appointment volume and clinician staffing on BP outcomes, nor any accounting for the likelihood of having BP observedan important methodological limitation of prior research.
Our findings and economic productivity models suggest that the health care organizations should be wary of increasing practice-level appointment volume without adjusting administrative and clinical capacity. Also, caution is warranted for practices considering augmenting provider staffing levels with additional part-time providers, which, although common in academic medical centers, may erode care continuity. 16 Comprehensive efforts to improve BP control through home BP monitoring and pharmacist medication management may succeed by delegating BP management to others. 7 However, our results suggest that, apart from such programs, levels of PCP staffing and practice appointment volume may also independently affect BP outcomes.
This study was limited by its use of data from a single, albeit large, clinical practice, and by its reliance on administrative staffing data and clinical data from the electronic medical record, which were not collected for research. We also had no additional data about clinician characteristics, provider continuity, or patient adherence to BP therapy. Yet, the combination of data sources, the identification of associations in data spanning 5 years, together with a modelling approach that accounts for the fact that BPs are only available when visits occur, suggests that this methodological approach may be valuable for others interested in examining the associations between clinical operations and clinical outcomes in similar settings that may also have such readily available data.
A heightened understanding of these relationships through analysis of the available observational data may inform clinical leaders' efforts to improve care through support for evidence-based appointment volume standards and better understanding of the implications of provider staffing arrangements.
